Open AccessSLCO3A1 expression is a major determinant of atazanavir PBMC penetration in HIV‐infected patients
Author(s) -
Siccardi M,
D'Avolio A,
Baietto L,
Simiele M,
Bonora S,
Back DJ,
Di Perri G,
Owen A
Publication year - 2010
Publication title -
journal of the international aids society
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.724
H-Index - 62
ISSN - 1758-2652
DOI - 10.1186/1758-2652-13-s4-p178
Subject(s) - medicine , atazanavir , ritonavir , peripheral blood mononuclear cell , pharmacology , pharmacokinetics , dosing , efflux , intracellular , therapeutic drug monitoring , viral load , concomitant , gastroenterology , immunology , human immunodeficiency virus (hiv) , antiretroviral therapy , biology , biochemistry , genetics , in vitro , microbiology and biotechnology
7‐11 November 2010, Tenth International Congress on Drug Therapy in HIV Infection, Glasgow, UK